» Articles » PMID: 10769134

Protease Nexin II Interactions with Coagulation Factor XIa Are Contained Within the Kunitz Protease Inhibitor Domain of Protease Nexin II and the Factor XIa Catalytic Domain

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2000 Apr 19
PMID 10769134
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Protease nexin II, a platelet-secreted protein containing a Kunitz-type domain, is a potent inhibitor of factor XIa with an inhibition constant of 250-400 pM. The present study examined the protein interactions responsible for this inhibition. The isolated catalytic domain of factor XIa is inhibited by protease nexin II with an inhibition constant of 437 +/- 62 pM, compared to 229 +/- 40 pM for the intact protein. Factor XIa is inhibited by a recombinant Kunitz domain with an inhibition constant of 344 +/- 37 pM versus 422 +/- 33 pM for the catalytic domain. Kinetic rate constants were determined by progress curve analysis. The association rate constants for inhibition of factor XIa by protease nexin II [(3.35 +/- 0.35) x 10(6) M(-1) s(-1)] and catalytic domain [(2.27 +/- 0. 25) x 10(6) M(-1) s(-1)] are nearly identical. The dissociation rate constants are very similar, (9.17 +/- 0.71) x 10(-4) and (7.97 +/- 1.1) x 10(-4) s(-1), respectively. The rate constants for factor XIa and catalytic domain inhibition by recombinant Kunitz domain are also very similar: association constants of (3.19 +/- 0.29) x 10(6) and (3.25 +/- 0.44) x 10(6) M(-1) s(-1), respectively; dissociation constants of (10.73 +/- 0.84) x 10(-4) and (10.36 +/- 1.3) x 10(-4) s(-1). The inhibition constant (K(i)) values calculated from these kinetic parameters are in close agreement with those measured from equilibrium binding experiments. These results suggest that the major interactions required for factor XIa inhibition by protease nexin II are localized to the catalytic domain of factor XIa and the Kunitz domain of protease nexin II.

Citing Articles

Pre-equilibrium competitive library screening for tuning inhibitor association rate and specificity toward serine proteases.

Cohen I, Naftaly S, Ben-Zeev E, Hockla A, Radisky E, Papo N Biochem J. 2018; 475(7):1335-1352.

PMID: 29535275 PMC: 5929103. DOI: 10.1042/BCJ20180070.


Suppressive Role of Tissue Factor Pathway Inhibitor-α in Platelet-Dependent Fibrin Formation under Flow Is Restricted to Low Procoagulant Strength.

Thomassen S, Mastenbroek T, Swieringa F, Winckers K, Feijge M, Schrijver R Thromb Haemost. 2018; 118(3):502-513.

PMID: 29452445 PMC: 5880031. DOI: 10.1055/s-0038-1627453.


Selection and characterization of a DNA aptamer inhibiting coagulation factor XIa.

Donkor D, Bhakta V, Eltringham-Smith L, Stafford A, Weitz J, Sheffield W Sci Rep. 2017; 7(1):2102.

PMID: 28522812 PMC: 5437010. DOI: 10.1038/s41598-017-02055-x.


P1 and P2' site mutations convert protease nexin-2 from a factor XIa inhibitor to a plasmin inhibitor.

Navaneetham D, Wu W, Li H, Sinha D, Tuma R, Walsh P J Biochem. 2012; 153(2):221-31.

PMID: 23172304 PMC: 3555081. DOI: 10.1093/jb/mvs133.


The kunitz protease inhibitor domain of protease nexin-2 inhibits factor XIa and murine carotid artery and middle cerebral artery thrombosis.

Wu W, Li H, Navaneetham D, Reichenbach Z, Tuma R, Walsh P Blood. 2012; 120(3):671-7.

PMID: 22674803 PMC: 3401218. DOI: 10.1182/blood-2012-03-419523.